Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

For many years the majority of pharmacy school teaching consisted of the chemistry and pharmaceutical aspects of a patient’s medication. This resulted in pharmacists who were more likely to spend their time preparing extemporaneous products than talking with patients. In recent years, however, the profession has come leaps and bounds in creating healthcare professionals with advanced clinical knowledge and exceptional patient care. This reform was imperative with the current strain ...

The scheme for the 2019 election provides for five places on the Royal Pharmaceutical Society English Pharmacy Board for Members or Fellows who work or live wholly or mainly in England, the Channel Islands or the Isle of Man. Full details of eligibility criteria are set out at https://www.rpharms.com/about-us/who-we

The scheme for the 2019 election provides for three places on the Royal Pharmaceutical Society Scottish Pharmacy Board for Members or Fellows who work or live wholly or mainly in Scotland. Full details of eligibility criteria are set out at https://www.rpharms.com/about-us/who-we-are/national-boards/boards-elections.

The scheme for the 2019 election provides for three places on the Royal Pharmaceutical Society Welsh Pharmacy Board for Members or Fellows who work or live wholly or mainly in Wales. The three places are to be allocated as follows:

Any member or Fellow who is resident in England, the Channel Islands or the Isle of Man at 17:00 on 5 April 2019 will be entitled to vote in the election of members of the Royal Pharmaceutical Society (RPS) English Pharmacy Board. Any Member or Fellow who is resident in Scotland at 17:00 on 5 April 2019 will be entitled to vote in the election of members of the RPS Scottish Pharmacy Board. Any member or Fellow who is resident in Wales at 17:00 on 5 April 2019 will be entitled to vote ...

By limiting repeat prescriptions for patients, the NHS — and in particular general practice — is protecting the UK from an opioid crisis similar to the one in the United States, the Royal College of General Practitioners has said.

Cuts of up to 25% in salary support for NHS preregistration trainees, announced by Health Education England in January 2019, will be “paused” for one year, according to a letter sent to hospital chief pharmacists on 19 February 2019.

The chair of the General Pharmaceutical Council has admitted he has concerns over the number of black, Asian and minority ethnic pharmacists who are suspended or removed from the register, compared with white pharmacists.

Community pharmacists are expected to play an essential role in a new campaign to help identify and treat people in England with undetected atrial fibrillation, high blood pressure or high cholesterol, the major causes of cardiovascular disease.

Topics discussed at the Royal Pharmaceutical Society Science and Research Summit included possible medicines shortages in the event of a no-deal Brexit, tackling antimicrobial resistance and the challenges of implementing the Falsified Medicines Directive.

The Pharmaceutical Group of the European Union says community pharmacy could use new technologies to dedicate more working time to providing patient care, use patient data to provide a more personalised healthcare service and utilise mobile health tools to identify at-risk patients.

As healthcare literacy increases, patients are taking more control over their treatment — it is important for these patients to know how community pharmacies can help them take action, ensuring access to the right care at the right time.

More than 44 million women could be diagnosed with cervical cancer in the next 50 years if high coverage human papillomavirus vaccination and cervical screening cannot be achieved globally, a modelling study published in The Lancet Oncology has found.

The Pharmaceutical Services Negotiating Committee has said that it hopes to start contract negotiations for community pharmacy “before Easter”, after the government promised the talks would start “shortly”.

Exclusive: The chair of the General Pharmaceutical Council has said he is “concerned” that planned cuts to preregistration training could make it more difficult to ensure that pharmacists can meet the changing demands of the NHS.

A no-deal Brexit could see the UK lose access to an EU-wide online tracker of infectious diseases and antimicrobial resistance, Dame Sally Davies, the chief medical officer for England, has told The Pharmaceutical Journal.

A GP IT service provider has said it will change its systems after it was revealed that GPs were able to prescribe “ghost branded generics”, costing the NHS an extra £11.6m per year in reimbursement to community pharmacy.

Exclusive: An estimated 64 million multicompartment compliance aids are given out by community pharmacies each year in England, a new report has shown, as data show rising reported incidences of associated harm.

Pharmacists have been asked to double-check fax numbers used to send medical documents after a hotel group reported receiving dispensing tokens and requests for medication from pharmacies in a personal data breach.